Mutations of PIK3CA, PIK3R1, and PIK3R2 are frequently detected in small-cell lung cancer (SCLC), non-small-cell lung cancer (NSCLC) [77], hepatocellular cancer [78], and ovarian serous cystadenocarcinoma [79]. Here, PIK3CA is linked to non-small cell lung carcinoma.